Not many three-year-olds have attained such an impressive pedigree, but the All of Us Research Program from the National Institutes of Health (NIH) is marking its latest birthday with a […]
Working with a wobbly institutional review board (IRB) is like “building a house on sand,” says Elizabeth Nelson, president of Regulatory Risk Management, LLC. Unfortunately, many clinical trial practitioners can’t […]
The clinical trial industry is clearly warming to the ideas behind decentralized clinical trials (DCTs), but it is ultimately patients who will drive the rate of adoption, says Dave Kelleher, […]
While the COVID-19 pandemic has splashed clinical trials news across the front pages and atop the nightly news for more than a year, the workforce remains something of a “hidden […]
Cancer clinical trial research rapidly adapted to the circumstances of enrolling and treating patients on clinical trials during the COVID-19 pandemic. That’s the conclusion drawn by authors of a study […]